Corrigendum to: The EVAPORATE trial provides important mechanistic data on plaque characteristics that have relevance to the REDUCE-IT results and clinical use of icosapent ethyl
European Heart Journal
21 June 2021
Organised by: 
You may be interested in
Congress Presentation
Congress Session
Congress Session
